-
Investigators will present findings from treatment phase of CATALYST trial
Researchers, including Vivian Fonseca, MD, will return to the Scientific Sessions with new data on mifepristone use to treat people with hypercortisolism and difficult-to-manage type 2 diabetes.
-
Session will explore the new frontier of adjunctive therapies in type 1 diabetes
Among the expert panelists, Klara R. Klein, MD, PhD, will explore the role of glucokinase activators in type 1 diabetes and the prevention of hypoglycemia.
-
Researchers to share weight loss results from bimagrumab and semaglutide combo
Steven B. Heymsfield, MD, and other panelists will explain insights into the treatment of obesity and overweight from BELIEVE.
-
Investigators to reveal full results from REDEFINE 1, 2 in Chicago
Melanie J. Davies, MB, ChB, MD, and other researchers will review data on combination therapy for weight loss using a fixed-dose combination of semaglutide and long-acting amylin analogue cagrilintide.
-
Symposium will explore next gen agents for type 2 diabetes and obesity
Panelists, including Dimitris Papamargaritis, MCRP, PhD, will discuss emerging therapies targeting the hormones glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin.
-
Speakers to stress importance of preparing for heart failure ‘tidal wave’
Adrian F. Hernandez, MD, MHS, and other experts will outline new developments in heart failure screening, prevention, and therapy related to diabetes.
-
Experts to explore using AI and diabetes tech to improve outcomes
Panelists including Mindy Lee, MD, PhD, and Yaa Kumah-Crystal, MD, MPH, will review recent advancements in medical technology and artificial intelligence and their potential clinical implications.
-
Debate to weigh benefits and drawbacks of OTC CGMs
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and David Ahn, MD, will assess the impact of non-prescription use of continuous glucose monitors.
-
Hot topics in diabetes fill Scientific Sessions program
Scientific Sessions Meeting Planning Committee Chair Mark A. Atkinson, PhD, highlights high-interest issues to be addressed by experts in the more than 200 sessions offered in Chicago.
-
Optimize your learning with innovative ideas and advance planning
Attendees at the Scientific Sessions are invited to ask questions of the diverse faculty and share novel ideas while taking advantage of world-class education.